Authors:
ZHANG HJ
MENG XL
ZHU L
ZHANG HZ
WANG P
DAWES J
WANG CQ
CHOW YT
Citation: Hj. Zhang et al., INVESTIGATIONS ON THE GROWTH AND LASER PROPERTIES OF ND-GDVO4 SINGLE-CRYSTAL, Crystal research and technology, 33(5), 1998, pp. 801-806
Citation: Pe. Smith et J. Dawes, ISOLATION OF A HUMAN PLATELET SURFACE HEPARIN-BINDING PROTEIN WITH HOMOLOGY TO ANTISTASIN, Thrombosis and haemostasis, 1997, pp. 1945-1945
Citation: D. Brieger et J. Dawes, PRODUCTION METHOD AFFECTS THE PHARMACOKINETIC AND EX-VIVO BIOLOGICAL PROPERTIES OF LOW-MOLECULAR-WEIGHT HEPARINS, Thrombosis and haemostasis, 77(2), 1997, pp. 317-322
Citation: D. Brieger et J. Dawes, LONG-TERM PERSISTENCE OF BIOLOGICAL-ACTIVITY FOLLOWING ADMINISTRATIONOF ENOXAPARIN SODIUM (CLEXANE) IS DUE TO SEQUESTRATION OF ANTITHROMBIN-BINDING LOW-MOLECULAR-WEIGHT FRAGMENTS - COMPARISON WITH UNFRACTIONATED HEPARIN, Thrombosis and haemostasis, 75(5), 1996, pp. 740-746
Citation: D. Brieger et J. Dawes, LOW-MOLECULAR-WEIGHT HEPARIN IS RESPONSIBLE FOR THE ANTI-XA ACTIVITY OF DESMIN-370, Thrombosis and haemostasis, 75(2), 1996, pp. 286-291
Authors:
MINTER AJ
KEOSHKERIAN E
CHESTERMAN CN
DAWES J
Citation: Aj. Minter et al., FIBROBLAST GROWTH-FACTOR AND HEPARIN PROTECT ENDOTHELIAL-CELLS FROM THE EFFECTS OF INTERLEUKIN-1, Journal of cellular physiology, 167(2), 1996, pp. 229-237
Citation: Aw. Ashton et al., ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS HAVE COMPARABLE EFFECTS ONTHE HEMOSTATIC FUNCTION OF VASCULAR ENDOTHELIUM, Growth factors, 12(2), 1995, pp. 111-120
Citation: Xe. Wells et J. Dawes, ROLE OF THE LIVER AND KIDNEY IN THE DESULFATION OF HEPARIN IN-VIVO, Thrombosis and haemostasis, 74(2), 1995, pp. 667-672
Citation: Xe. Wells et J. Dawes, ROLE OF THE LIVER AND KIDNEY IN THE DESULFATION OF HEPARIN IN-VIVO, Thrombosis and haemostasis, 73(6), 1995, pp. 970-970
Citation: A. Zammit et J. Dawes, LOW-AFFINITY HEPARIN POTENTIATES THE ANTI-XA BUT NOT THE ANTI-IIA ACTIVITY OF HIGH-AFFINITY HEPARIN IN HUMAN PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 970-970
Citation: P. Smith et J. Dawes, HEPARIN-BINDING PROTEINS ON THE SURFACE OF ACTIVATED AND UNACTIVATED HUMAN PLATELETS, Thrombosis and haemostasis, 73(6), 1995, pp. 1196-1196
Citation: D. Brieger et J. Dawes, THE ANTI-XA ACTIVITY OF DESMIN 370 IS ATTRIBUTABLE TO LOW-MOLECULAR-WEIGHT HEPARIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1351-1351
Citation: Pg. Bannon et al., AUGMENTATION OF VASCULAR ENDOTHELIAL BARRIER FUNCTION BY HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN, Thrombosis and haemostasis, 73(4), 1995, pp. 706-712
Citation: A. Zammit et J. Dawes, FIBRINOGEN INHIBITS THE HEPARIN-COFACTOR II-MEDIATED ANTITHROMBIN ACTIVITY OF DERMATAN SULFATE, Blood, 85(3), 1995, pp. 720-726
Citation: C. Ang et J. Dawes, THE EFFECTS OF HYPERTHERMIA ON HUMAN ENDOTHELIAL MONOLAYERS - MODULATION OF THROMBOTIC POTENTIAL AND PERMEABILITY, Blood coagulation & fibrinolysis, 5(2), 1994, pp. 193-199
Citation: Pg. Bannon et al., MALFORMIN A PREVENTS IL-1 INDUCED ENDOTHELIAL CHANGES BY INHIBITION OF PROTEIN-SYNTHESIS, Thrombosis and haemostasis, 72(3), 1994, pp. 482-483
Citation: D. Brieger et J. Dawes, CHARACTERIZATION OF PERSISTENT ANTI-XA ACTIVITY FOLLOWING ADMINISTRATION OF THE LOW-MOLECULAR-WEIGHT HEPARIN ENOXAPARIN SODIUM (CLEXANE), Thrombosis and haemostasis, 72(2), 1994, pp. 275-280
Citation: A. Zammit et J. Dawes, LOW-AFFINITY MATERIAL DOES NOT CONTRIBUTE TO THE ANTITHROMBOTIC ACTIVITY OF ORGARAN (ORG-10172) IN HUMAN PLASMA, Thrombosis and haemostasis, 71(6), 1994, pp. 759-767